Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
Yan Xue, Li-Xin Zhang, Lei Wang, Tao Li, Yun-Dong Qu, Feng Liu, Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, Jinan 250033, Shandong Province, China
Author contributions: Xue Y and Zhang LX contributed equally to this work; Wang L, Li T, Qu YD and Liu F conceived the study; Wang L, Xue Y and Zhang LX designed the research; Wang L, Xue Y and Zhang LX collected the data; Xue Y, Zhang LX and Qu YD analyzed the data; Xue Y wrote the article; Xue Y, Zhang LX and Li T revised the manuscript for final submission; Wang L participated in the study supervision.
Supported by the Project of Science and Technology Development Plan of Jinan City, No. 201506004; and Youth Fund of the Second Hospital of Shandong University, No. Y2014010014.
Institutional review board statement: The study protocol was approved by the Ethical Committee of the Second Hospital of Shandong University.
Informed consent statement: Written informed consent was obtained from all patients.
Conflict-of-interest statement: All authors have no conflicts of interest.
Data sharing statement: There are no additional data available in relation to this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Lei Wang, PhD, MD, Professor, Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, 247 Beiyuan Road, Jinan 250033, Shandong Province, China. email@example.com
Received: May 31, 2017
Peer-review started: May 31, 2017
First decision: June 22, 2017
Revised: July 3, 2017
Accepted: July 12, 2017
Article in press: July 12, 2017
Published online: August 28, 2017